Antifungal Susceptibility Testing

Dear Colleagues,

For many years, only one compound was available to treat serious fungal infections. Fortunately, in the last few decades, several other drugs and families have been licenced and, nowadays, there are several therapeutic options to treat patients with these diseases. The number of species able to cause fungal infections has increase exponentially in the last few years. These fungal species have different susceptibility profiles that can vary, even within strains of the same species. In addition, as you might know, antifungal resistance is emerging worldwide in the last years threatening the outcome of patients infected with resistant isolates and becoming a public health threat. This resistance is emerging both in Candida and Aspergillus and in azoles and echinocandins. As a result, knowing the antifungal susceptibility profile and detection of antifungal resistance are essential to manage patients affected with fungal infections. Two organizations: The European, EUCAST and the American, CLSI have intensively worked towards standardized methods for antifungal susceptibility testing and have developed interpretative breakpoints to define antifungal resistance. However, other commercial methods are developed providing comparable results that are increasingly used in the clinical setting. Therefore, nowadays, antifungal susceptibility tests have become essential tools to detect resistance, to guide treatment and to study epidemiology in different settings.

Dr. Ana Alastruey-Izquierdo
Dr. Stéphane Ranque
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.